<SEC-DOCUMENT>0001628280-18-003199-index.html : 20180315
<SEC-HEADER>0001628280-18-003199.hdr.sgml : 20180315
<ACCEPTANCE-DATETIME>20180314174410
ACCESSION NUMBER:		0001628280-18-003199
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		3
FILED AS OF DATE:		20180315
DATE AS OF CHANGE:		20180314
EFFECTIVENESS DATE:		20180315

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		18690454

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>a2018additionaldefinitivep.htm
<DESCRIPTION>DEFA14A 2018 ADDITIONAL DEFINITIVE PROXY MATERIALS
<TEXT>
Document 1 - file: a2018additionaldefinitivep.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>cumberlandlogo.jpg
<TEXT>
Document 2 - file: cumberlandlogo.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>internetimage.jpg
<TEXT>
Document 3 - file: internetimage.jpg

</DOCUMENT>
</SEC-DOCUMENT>